- Frame messaging on why doing clinical trial as based on Trichuris burden – evidence for clinical trial most clear as albendazole is less effective and we have decent burden data; Reinforce messaging that will be a clinical trial, building on and using MDA architecture as much as possible
- GHS to review external communications plan – Tuesday 19th
- All/Mundo Sano facilitate
- Circulate and review materials from past MDA and/or relevant trials from communications/social mobilization
- Circulate and review materials from past MDA and/or relevant trials from communications/social mobilization (GHS has already circulated)
- Align on targeted changes for Ghana and for Kenya (meeting with Kenya scheduled for December 19th with the Comms team)
- Consdiera how to reflect non-STH diseases also addressed by the FDC (e.g. onchocercosis, )